Brief: Agios Pharmaceuticals Q3 Product Revenue USD 8.964 Million
31/10/2024 10:30
Oct 31 (Reuters) - Agios Pharmaceuticals Q3 net income USD 947.915 million vs. IBES estimate USD -101.5 million
Recent news on Agios Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Agios Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Agios Q2 revenue jumps on US commercial launch of AQVESME
Brief: Agios Pharmaceuticals Q2 Product Revenue USD 44.745 Million Vs. IBES Estimate USD 25.5 Million